Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Leflunomide and teriflunomide: altering the metabolism of pyrimidines for the treatment of autoimmune diseases.
EAE is not a useful model for demyelinating disease.
Burden of risk variants correlates with phenotype of multiple sclerosis.
Central Autonomic Dysfunction Delays Recovery of Fingolimod Induced Heart Rate Slowing.
IL-27 Limits Central Nervous System Viral Clearance by Promoting IL-10 and Enhances Demyelination.
Smoking increases the risk of multiple sclerosis in Queensland, Australia.
Cognitive and brain reserve for mind-body therapeutic approaches in multiple sclerosis: A review.
Allopregnanolone and neuroinflammation: a focus on multiple sclerosis.
[Neuromyelitis optica].
Functional outcomes associated with expiratory muscle strength training: Narrative review.
Can a physician predict the clinical response to first-line immunomodulatory treatment in relapsing-remitting multiple sclerosis?
Distilling the essence of appraisal: a mixed methods study of people with multiple sclerosis.
Defining Quality of Life Levels to Enhance Clinical Interpretation in Multiple Sclerosis: Application of a Novel Clustering Method.
Involvement of Toso in activation of monocytes, macrophages, and granulocytes.
Elevated Lipid Profiles in Patients with Acute Transverse Myelitis.
Circadian gene Bmal1 regulates diurnal oscillations of Ly6C(hi) inflammatory monocytes.
Source of iron overload in multiple sclerosis.
Evaluation of efficacy, safety and tolerability of fingolimod in patients with the relapsing form of multiple sclerosis - 12-month observation. A preliminary report.
Quality of life in patients with multiple sclerosis.
The role of invariant NKT cells in organ-specific autoimmunity.
Verbal fluency deficits in clinically isolated syndrome suggestive of multiple sclerosis.
Promotion of experimental autoimmune encephalomyelitis upon neutrophil granulocytes' stimulation with formyl-methionyl-leucyl-phenylalanine (fMLP) peptide.
Impaired Cerebrovascular Reactivity in Multiple Sclerosis.
Clinical use of brain volumetry.
Histological correlation of diffusional kurtosis and white matter modeling metrics in cuprizone-induced corpus callosum demyelination.
Pages
« first
‹ previous
…
362
363
364
365
366
367
368
369
370
…
next ›
last »